NBTX

Nanobiotix S.A.

Price

$20.99

return (12m)

-18.01%

p/e

-10.45

p/bv

-10.56

DIVIDEND YIELD

0.00%

NBTX price

Nanobiotix

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment NBTX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-38.26%

3 months

-45.54%

1 year

-18.01%

2 years

343.76%

5 years

62.32%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals NBTX

Valuation

P/E

-10.45

Sector -3.10

Industry -3.10

P/BV

-10.56

Sector 1.77

Industry 1.77

P/Revenue (PSR)

43.05

Sector 2.01

Industry 2.01

EV/EBITDA

-79.12

Sector -216.68

Industry -216.68

EV/EBIT

-74.71

Sector -46.14

Industry -46.14

P/EBITDA

-13.80

Sector -21.54

Industry -21.54

P/EBIT

-13.20

Sector -27.94

Industry -27.94

P/Total Assets

13.16

Sector 1.05

Industry 1.05

P/Net Current Assets

-9.97

Sector -9.24

Industry -9.24

P/Working Capital

170.11

Sector -135.45

Industry -135.45

EPS

-2.08

Sector -1.78

Industry -1.78

BVPS

-2.06

Sector 1.99

Industry 1.99

Efficiency

Gross Margin

100.00%

Sector 41.24%

Industry 41.24%

EBITDA Margin

-248.91%

Sector -17,192.92%

Industry -17,192.92%

EBIT Margin

-100.00%

Sector -35.37%

Industry -35.37%

Net Profit Margins

-100.00%

Sector -35.81%

Industry -35.81%

Asset Turnover

0.07

Sector 0.03

Industry 0.03

Profitability

ROE

101.02%

Sector -57.47%

Industry -57.47%

ROA

-125.96%

Sector -59.48%

Industry -59.48%

ROIC

-49.05%

Sector -2,385.22%

Industry -2,385.22%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

1.09

Sector 2.92

Industry 2.92

Net Debt / EBITDA

-3.10

Sector -21.38

Industry -21.38

Net Debt / EBIT

-2.93

Sector -8.29

Industry -8.29

Net Debt / Equity

-0.43

Sector -33,113.00

Industry -33,113.00

Gross Debt / Equity

-1.05

Sector -0.84

Industry -0.84

Equity/Assets

-1.25

Sector 0.46

Industry 0.46

Liabilities/Assets

2.25

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

72.49%

Sector -

Industry -

5Y Earnings CAGR

12.53%

Sector -

Industry -

Fundamentals NBTX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
NBTX Nanobiotix S.A.	$20.99	-18.01%	0.00%	-10.45	-10.56	101.02%	-100.00%
PFE Pfizer Inc.	$29.30	29.93%	5.91%	38.29	1.94	5.07%	6.80%
ABBV AbbVie Inc.	$283.02	27.22%	2.40%	79.71	-84.84	-106.44%	9.81%
NVO Novo Nordisk A/S	$38.44	-25.78%	4.74%	9.57	5.08	53.11%	35.32%
MRK Merck & Co. Inc.	$144.69	75.65%	2.34%	113.15	8.55	7.56%	4.77%
AZN AstraZeneca PLC	$165.06	-0.87%	1.95%	19.76	5.09	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$58.66	42.28%	4.19%	13.18	5.48	41.59%	18.87%
ZTS Zoetis Inc.	$79.45	-43.79%	2.64%	12.52	10.49	83.77%	27.69%
AMGN Amgen Inc.	$426.52	46.68%	2.29%	26.86	20.10	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$782.52	35.91%	0.47%	18.88	2.58	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$122.82	83.23%	0.00%	34.40	99.12	288.13%	24.86%
MCK McKesson Corporation	$994.67	27.04%	0.34%	25.91	-30.79	-118.84%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$502.58	20.58%	0.00%	29.00	6.31	21.76%	35.00%
CAH Cardinal Health Inc.	$250.05	61.38%	0.81%	34.89	-21.95	-62.92%	0.67%
ARGX argenx SE	$820.58	-2.74%	0.00%	13.83	3.67	26.52%	25.54%
HRMY Harmony Biosciences Holdings Inc.	$37.50	44.79%	0.00%	12.22	2.22	18.14%	18.88%
BIIB Biogen Inc.	$232.87	62.85%	0.00%	41.65	1.84	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

NBTX - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Nanobiotix

Nanobiotix S.A.

Average Investor10 user rating

4.0 (4 people)

United States

23 years

Founded: 2003

2020

Time since IPO - 6 years

88

Employees

Nanobiotix S.A. (United States) is listed on the Nasdaq and has a market capitalization of $1.04 billion, with shareholders equity totaling $-98.93 million.

The company employs approximately 88 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Nanobiotix S.A. reported $24.26 million in revenue, generating net income of $-99.94 million.

Key financial metrics include a P/E ratio of -10.45, a price-to-book (P/B) ratio of -10.56, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker NBTX.

Market cap

$1.04 billion

Net worth

$-98.93 million

$-98,930,000.00

Assets

$79.34 million

$79,340,000.00

Total Shares Outstanding

48.00 million

48,000,000

Average Daily Trading Volume

$156.31 Thousand

$156,311.66

Sector

Health Care

Industry

Biotechnology

NBTX

NBTX revenue and profits

Financial Results NBTX

DRAG THE FRAME TO SEE MORE DATA

NBTX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$994.67 27,04% (12M)

P/E

25.91

0.34%

ROE

-118.84%

P/BV

-30.79

CAH - Cardinal Health

$250.05 61,38% (12M)

P/E

34.89

0.81%

ROE

-62.92%

P/BV

-21.95

ABBV - AbbVie

$283.02 27,22% (12M)

P/E

79.71

2.40%

ROE

-106.44%

P/BV

-84.84

MRK - Merck & Co.

$144.69 75,65% (12M)

P/E

113.15

2.34%

ROE

7.56%

P/BV

8.55

AZN - AstraZeneca

$165.06 0,10% (12M)

P/E

19.76

1.95%

ROE

25.77%

P/BV

5.09

PFE - Pfizer

$29.30 29,93% (12M)

P/E

38.29

5.91%

ROE

5.07%

P/BV

1.94

BMY - Bristol-Myers Squibb

$58.66 42,28% (12M)

P/E

13.18

4.19%

ROE

41.59%

P/BV

5.48

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$994.67 27,04% (12 M)

P/L

25.91

0.34%

ROE

-118.84%

P/VP

-30.79

CAH - Cardinal Health

$250.05 61,38% (12 M)

P/L

34.89

0.81%

ROE

-62.92%

P/VP

-21.95

ABBV - AbbVie

$283.02 27,22% (12 M)

P/L

79.71

2.40%

ROE

-106.44%

P/VP

-84.84

MRK - Merck & Co.

$144.69 75,65% (12 M)

P/L

113.15

2.34%

ROE

7.56%

P/VP

8.55

AZN - AstraZeneca

$165.06 0,10% (12 M)

P/L

19.76

1.95%

ROE

25.77%

P/VP

5.09

PFE - Pfizer

$29.30 29,93% (12 M)

P/L

38.29

5.91%

ROE

5.07%

P/VP

1.94

BMY - Bristol-Myers Squibb

$58.66 42,28% (12 M)

P/L

13.18

4.19%

ROE

41.59%

P/VP

5.48

Frequently Asked Questions

What is the price of Nanobiotix (NBTX) today?

The current price of Nanobiotix (NBTX) is $20.99. The stock began the year trading around $23.12 and is currently priced at $20.99. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Nanobiotix (NBTX) pay dividends?

Nanobiotix (NBTX) did not pay dividends over the past year.

Is Nanobiotix (NBTX) a good investment?

Nanobiotix (NBTX) is currently trading at $20.99 with a P/E ratio of -10.45. This represents a -388% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was -18.01%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Nanobiotix (NBTX) stock?

You can buy Nanobiotix (NBTX) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol NBTX and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Nanobiotix (NBTX) yield today?

Over the past month, Nanobiotix (NBTX) has returned -38.26% — -18.01% over the past year, and 62.32% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Nanobiotix (NBTX) today at the current price of $20.99 your total investment would be $2,099.00.

Based on historical performance, the investment would have grown to approximately:

$1,720.97 after 1 year
$3,407.10 after 5 years
$2,099.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

NBTX

Nanobiotix S.A.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment NBTX

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING NBTX WITH OTHER STOCK

ABOUT Nanobiotix

Nanobiotix S.A.

United States

23 years

2020

88

PROFIT X PRICE NBTX

Financial Results NBTX

NBTX cash flow

Asset, Revenue and Profit Growth - NBTX

NBTX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

Frequently Asked Questions